Public health management of group A streptococcal infection in mother-baby pairs in England; a case series review
© Howard et al; licensee BioMed Central Ltd. 2015
Published: 16 June 2015
Group A streptococci (GAS) are causative organisms in a large and increasing proportion of UK puerperal sepsis deaths, and remain an important consideration in neonatal sepsis in the UK and around the world. UK guidelines advise that both mother and baby should be treated with antibiotics if either develops an invasive GAS (iGAS) infection in the 28 days following birth to reduce the risk of iGAS developing in the other party.
To assess compliance with the UK guidelines in mothers who develop GAS infection in the puerperium over a 2-year period across the North East of England.
We reviewed records of all cases of GAS infection notified to the North East Health Protection Team (part of Public Health England) between 1 Sep 2012 and 31 Aug 2014 in women who had given birth in the preceding 28 days. We assessed whether antibiotics had been prescribed in each case, and the process through which antibiotic prescription had been arranged.
In 19 of 24 pairs, both mother and baby received antibiotics, though 2 babies received courses which deviated from the guidance. The hospital treating the mother prescribed antibiotics for the baby in 14 pairs, though agreed to do so only after consultant intervention in 3 of these pairs. GPs prescribed antibiotics for 5 remaining treated babies.
In 2 pairs, only the mother received antibiotics.
In 3 pairs, neither mother nor baby received antibiotics.
Some variation is explained by the clinical picture: there is little rationale to treat mothers (or babies of mothers) who have GAS isolated on microbiological samples but whose clinical picture does not suggest iGAS infection.
Some variation resulted from poor understanding: 2 babies were not prescribed antibiotics as they were assessed as "clinically well", missing the point of antibiotic prophylaxis. Some junior staff refused to prescribe antibiotics until instructed to do so by a consultant.
To improve consistency of practice, the Health Proteciton Team is developing a regional protocol for treatment of puerperal GAS cases in conjunction with clinical colleagues.
Disclosure of interest
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.